Cargando…

Transcription-based drug repurposing for COVID-19

We have utilised the transcriptional response of lung epithelial cells following infection by the original Severe Acute Respiratory Syndrome coronavirus (SARS) to identify repurposable drugs for COVID-19. Drugs best able to recapitulate the infection profile are highly enriched for antiviral activit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Killick, Richard, Ballard, Clive, Doherty, Patrick, Williams, Gareth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518800/ https://www.ncbi.nlm.nih.gov/pubmed/32987033 http://dx.doi.org/10.1016/j.virusres.2020.198176

Ejemplares similares

Drug repurposing for Alzheimer’s disease based on transcriptional profiling of human iPSC-derived cortical neurons
por: Williams, Gareth, et al.
Publicado: (2019)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
por: Killick, Richard, et al.
Publicado: (2023)

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
por: Norinder, Ulf, et al.
Publicado: (2020)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis
por: Perez-Garcia, Luis A., et al.
Publicado: (2020)

Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?
por: Pereira, Anna Karla dos Santos, et al.
Publicado: (2021)

The use of genomic variants to drive drug repurposing for chronic hepatitis B
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents
por: Su, Li, et al.
Publicado: (2020)

Ivermectin: Potential Role as Repurposed Drug for COVID-19
por: Dixit, Alok, et al.
Publicado: (2020)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Through Computational Approach
por: Vaseghi, Golnaz, et al.
Publicado: (2022)

L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies
por: Sendama, Wezi
Publicado: (2020)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
por: Corbett, Anne, et al.
Publicado: (2013)

Cholesterol-modifying drugs in COVID-19
por: Schmidt, Nathalie M, et al.
Publicado: (2020)

Advancements in Drug Repurposing: Examples in Psychiatric Medications
por: Okuyama, Ryo
Publicado: (2023)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Repurposing Positive SARS-CoV-2 Antigen Test Devices for Variant Tracking
por: Urrutikoetxea-Gutierrez, Mikel, et al.
Publicado: (2022)

Computational-based drug repurposing methods in COVID-19
por: Masoudi-Sobhanzadeh, Yosef
Publicado: (2020)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Perspective: repurposed drugs for COVID-19
por: Na-Bangchang, Kesara, et al.
Publicado: (2022)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing
por: Jermain, Brian, et al.
Publicado: (2020)

Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani
por: Hassan, Ahmed H. E., et al.
Publicado: (2023)

COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020)

Repurposing Antiviral Drugs for Orthogonal RNA‐Catalyzed Labeling of RNA
por: Ghaem Maghami, Mohammad, et al.
Publicado: (2020)

High Efficiency Drug Repurposing Design for New Antifungal Agents
por: Kim, Jong H., et al.
Publicado: (2019)

Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs
por: Niculescu, A. B., et al.
Publicado: (2019)

A network based efficient drug repurposing strategy for targeting diabesity
por: Dutta, Subhajit, et al.
Publicado: (2022)

Shifts in drug seizures in the United States during the COVID-19 pandemic
por: Palamar, Joseph J., et al.
Publicado: (2021)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Repurposing antimalarials and other drugs for COVID-19
por: Schlagenhauf, Patricia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rnmchfp7s2jpn23e6gq54q7c13